EDGAR Filing Documents for 0000950170-24-073256

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000950170-24-073256

Filing Date

2024-06-13

Accepted

2024-06-13 20:00:10

Documents

Period of Report

2024-06-11

Document Format Files

Seq	Description	Document	Type	Size
1	4	ownership.html	4
1	4	ownership.xml	4	3520
	Complete submission text file	0000950170-24-073256.txt		5049

Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472

Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583

iTeos Therapeutics, Inc. (Issuer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ITEOS THERAPEUTICS, INC 321 ARSENAL ST BLDG 312, SUITE 301 WATERTOWN MA 02472

Business Address

Lee David K (Reporting) CIK: 0002002238 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39401 | Film No.: 241042725